01/11 | ADAPTIVE BIOTECHNOLOGIES : Partners With AstraZeneca to Use ImmunoSEQ T-MAP in O.. | MT |
01/11 | Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immun.. | GL |
2020 | Adaptive Biotechnologies to Present at the 39th Annual J.P. Morgan Healthcare.. | GL |
2020 | IQVIA-Quest Diagnostics Joint Venture Q2 Form Marketing Partnership With Adap.. | MT |
2020 | ADAPTIVE BIOTECHNOLOGIES : Investor Presentation - December 2020 | PU |
2020 | Adaptive Biotechnologies Announces New Clinical Data Demonstrating Impact of .. | GL |
2020 | ADAPTIVE BIOTECHNOLOGIES : and Collaborators to Present Data from More Than 35 A.. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES : and Collaborators to Present Data from More Than 35 A.. | AQ |
2020 | Adaptive Biotechnologies and Collaborators to Present Data from More Than 35 .. | GL |
2020 | ADAPTIVE BIOTECHNOLOGIES : Preliminary Data from Real-World Study Demonstrate T-.. | AQ |
2020 | Adaptive Biotechnologies Says Data Showed T-Detect Assay Better Identifies Pa.. | MT |
2020 | ADAPTIVE BIOTECHNOLOGIES : Preliminary Data from Real-World Study Demonstrate T-.. | AQ |
2020 | Preliminary Data from Real-World Study Demonstrate T-cell Testing Outperforms.. | GL |
2020 | ADAPTIVE BIOTECHNOLOGIES CORP : Other Events (form 8-K) | AQ |
2020 | BTIG Research Adjusts Adaptive Biotechnologies PT to $63 From $60, Maintains .. | MT |
2020 | SECTOR UPDATE : Late Slump Drags Health Care Stocks Underwater | MT |
2020 | SECTOR UPDATE : Health Care Stocks Hanging On For Narrow Rise | MT |
2020 | Goldman Sachs Adjusts Price Target for Adaptive Biotechnologies to $66 From $.. | MT |
2020 | JP Morgan Adjusts Price Target for Adaptive Biotechnologies to $60 From $50, .. | MT |
2020 | Morgan Stanley Adjusts Adaptive Biotechnologies PT to $46 From $42, Maintains.. | MT |
2020 | Adaptive Biotechnologies Widens Q3 Loss But Results Surpass Street Views | MT |
2020 | ADAPTIVE BIOTECHNOLOGIES : Management's Discussion and Analysis of Financial Con.. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES CORP : Results of Operations and Financial Condition, F.. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES : 3Q Earnings Snapshot | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES : Announces Collaboration with GSK to Measure Minimal R.. | AQ |
2020 | Adaptive Biotechnologies Announces Collaboration with GSK to Measure Minimal .. | GL |
2020 | Earnings Flash (ADPT) ADAPTIVE BIOTECHNOLOGIES Reports Q3 Revenue $26.3M, vs... | MT |
2020 | ADAPTIVE BIOTECHNOLOGIES : Reports Third Quarter 2020 Financial Results | AQ |
2020 | Adaptive Biotechnologies Reports Third Quarter 2020 Financial Results | GL |
2020 | ADAPTIVE BIOTECHNOLOGIES CORPORATION : quaterly earnings release | |
2020 | ADAPTIVE BIOTECHNOLOGIES CORP : Change in Directors or Principal Officers (form .. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES : to Report Third Quarter Financial Results on November.. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES : to Report Third Quarter Financial Results on November.. | AQ |
2020 | Adaptive Biotechnologies to Report Third Quarter Financial Results on Novembe.. | GL |
2020 | Adaptive Biotechnologies to Present at the Morgan Stanley 2020 Healthcare Con.. | GL |
2020 | ADAPTIVE BIOTECHNOLOGIES CORP : Other Events, Financial Statements and Exhibits .. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES : to Present at the UBS Genomics 2.0 and Medtech Innova.. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES : 2Q Earnings Snapshot | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES : Management's Discussion and Analysis of Financial Con.. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES CORP : Results of Operations and Financial Condition, F.. | AQ |
2020 | Adaptive Biotechnologies Reports Second Quarter 2020 Financial Results | GL |
2020 | Adaptive Biotechnologies to Present at the UBS Genomics 2.0 and Medtech Innov.. | GL |
2020 | ADAPTIVE BIOTECHNOLOGIES : Receives Expanded FDA Clearance for the clonoSEQ Assa.. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES : Receives Expanded FDA Clearance for the clonoSEQ® Ass.. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES CORPORATION : half-yearly earnings release | |
2020 | ADAPTIVE BIOTECHNOLOGIES : Launches immunoSEQ T-MAP COVID, First Molecular T Cel.. | AQ |
2020 | FOCUS : Next big COVID-19 treatment may be manufactured antibodies | RE |
2020 | Adaptive Biotechnologies Launches National Clinical Trial to Develop Novel T-.. | GL |
2020 | ADAPTIVE BIOTECHNOLOGIES CORP : Entry into a Material Definitive Agreement, Resu.. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES : Announces Pricing of Public Offering of Common Stock | AQ |
2020 | Adaptive Biotechnologies Announces Proposed Public Offering of Common Stock | GL |
2020 | Adaptive Biotechnologies to Report Second Quarter Financial Results on August.. | GL |
2020 | How Moderna executives are cashing in on COVID-19 vaccine stock speculation | RE |
2020 | ADAPTIVE BIOTECHNOLOGIES CORP : Change in Directors or Principal Officers (form .. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES CORP : Submission of Matters to a Vote of Security Hold.. | AQ |
2020 | UPDATE – Adaptive Biotechnologies to Participate in Upcoming June Inves.. | GL |
2020 | ADAPTIVE BIOTECHNOLOGIES : to Participate in Upcoming June Investor Conferences | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES : Management's Discussion and Analysis of Financial Con.. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES CORP : Results of Operations and Financial Condition, F.. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES : 1Q Earnings Snapshot | AQ |
2020 | Adaptive Biotechnologies Reports First Quarter 2020 Financial Results | GL |
2020 | Adaptive Biotechnologies to Present at the BofA Securities 2020 Healthcare Co.. | GL |
2020 | ADAPTIVE BIOTECHNOLOGIES CORP : Regulation FD Disclosure, Financial Statements a.. | AQ |
2020 | Amgen studying Otezla for coronavirus, looking into other treatments | RE |
2020 | Adaptive Biotechnologies to Report First Quarter Financial Results on May 12,.. | GL |
2020 | Adaptive Biotechnologies Expands Executive Leadership Team to Support Develop.. | GL |
2020 | Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 .. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES CORP : Regulation FD Disclosure, Financial Statements a.. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES : 4Q Earnings Snapshot | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES : Management's Discussion and Analysis of Financial Con.. | AQ |
2020 | ADAPTIVE BIOTECHNOLOGIES CORP : Results of Operations and Financial Condition, F.. | AQ |
2020 | Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2019 Financial .. | GL |
2020 | Adaptive Biotechnologies to Present at the 40th Annual Cowen Health Care Conf.. | GL |
2020 | ADAPTIVE BIOTECHNOLOGIES CORP : Change in Directors or Principal Officers (form .. | AQ |
2020 | Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2019 Financia.. | GL |